Institutional Manager · CIK 0001845151
MWG Management Ltd.
Washington, DC · File #028-21024
Latest AUM
$81.3M
Positions
3
Top-10 Concentration
100.0%
Filings
8
Portfolio Value Over Time
2023-12
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | LYELL IMMUNOPHARMA INC | 55083R203 | +1,008,116 | +$16.4M | $0 |
| EXITED | LYELL IMMUNOPHARMA INC | 55083R104 | -1,008,116 | -$8.9M | $0 |
| REDUCE | BEAM THERAPEUTICS INC | 07373V105 | 0 | $0 | +$16.5M |
| REDUCE | PRIME MEDICINE INC | 74168J101 | 0 | $0 | +$5.5M |
Filing History
- 13F HOLDINGS REPORTQ/E Sep 20253 pos · $81.3M
- 13F HOLDINGS REPORTQ/E Jun 20253 pos · $51.9M
- 13F HOLDINGS REPORTQ/E Mar 20253 pos · $58.7M
- 13F HOLDINGS REPORTQ/E Dec 20243 pos · $74.4M
- 13F HOLDINGS REPORTQ/E Sep 20243 pos · $90.3M
- 13F HOLDINGS REPORTQ/E Jun 20243 pos · $91.6M
- 13F HOLDINGS REPORTQ/E Mar 20243 pos · $135.1M
- 13F HOLDINGS REPORTQ/E Dec 20233 pos · $103.2M
Top 3 Holdings — Sep 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | BEAM THERAPEUTICS INC | 07373V105 | 2,266,934 | $55.0M | 67.66% |
| 2 | LYELL IMMUNOPHARMA INC | 55083R203 | 1,008,116 | $16.4M | 20.13% |
| 3 | PRIME MEDICINE INC | 74168J101 | 1,792,210 | $9.9M | 12.21% |